Trials / Conditions / Natural Killer/T-cell Lymphoma
Natural Killer/T-cell Lymphoma
6 registered clinical trials studyying Natural Killer/T-cell Lymphoma — 5 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | PD-1 Antibody-based Therapy With Concurrent RT for Early-stage NKTCL NCT07380984 | Ruijin Hospital | Phase 2 |
| Not Yet Recruiting | Multi-modal Fusion Model and Deep Learning for Predicting Treatment Response in NKTCL NCT07409168 | Sun Yat-sen University | — |
| Recruiting | A Phase Ib/II Clinical Study Evaluating the Safety and Efficacy of Tislelizumab in Combination With Golidociti NCT06966154 | Fudan University | Phase 1 / Phase 2 |
| Recruiting | Phase II Study of Golidocitinib and Benmelstobart in Patients with R/R ENKTL (JACKPOT50) NCT06733051 | Sun Yat-sen University | Phase 2 |
| Recruiting | Study of Isatuximab and Cemiplimab in Relapsed or Refractory Natural Killer/T-cell Lymphoid Malignancy NCT04763616 | Won Seog Kim | Phase 2 |
| Unknown | Predictive Value of a SNP Signature and Liquid Biopsy in Natural Killer T-cell Lymphoma NCT04423536 | Sun Yat-sen University | — |